| HOME >> BIOLOGY >> TECHNOLOGY |
References
1. Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna,
M. T., Lesser, M., New, M. I., and White, P. C., Disease expression and
molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase
deficiency, J. Clin. Invest., 90, 58495 (1992).
2. Barbat, B., Bogyo, A., Raux-Demay, M. C., Kuttenn, F., Boue, J., Simon- Bouy, B., Serre, J. L., and Mornet, E., Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency, Hum. Mutat., 5, 12630 (1995).
3. Wedell, A., Thilen, A., Ritzen, E. M., Stengler, B., and Luthman, H., Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation, J. Clin. Endocrinol. Metab., 78, 114552 (1994).
4. Ezquieta, B., Oliver, A., Gracia, R., and Gancedo, P. G., Analysis of steroid 21-hydroxylase gene mutations in the Spanish population, Hum. Genet., 96, 198204 (1995).
5. Lajic, S., and Wedell, A., An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasia, Hum. Genet., 98(2):1824 (1996).
6. Levo, A., and Partanen, J., Novel nonsense mutation (W302X) in the
steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting
form of congenital adrenal hyperp
'"/>
Source: